J. B. Chemicals & Pharmaceuticals Limited (BOM:506943)
India · Delayed Price · Currency is INR 1,892.70
-12.05 (-0.63%)
At close: Feb 13, 2026
BOM:506943 Market Cap
BOM:506943 has a market cap or net worth of 305.76 billion as of February 13, 2026. Its market cap has increased by 10.42% in one year.
Market Cap
305.76B
Enterprise Value
300.23B
Revenue
41.93B
Ranking
n/a
PE Ratio
40.13
Stock Price
1,892.70
Market Cap Chart
Since December 11, 2001, BOM:506943's market cap has increased from 408.70M to 305.76B, an increase of 74,713.75%. That is a compound annual growth rate of 31.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 305.76B | 7.22% |
| Dec 31, 2025 | 285.18B | -0.62% |
| Dec 31, 2024 | 286.94B | 13.93% |
| Dec 29, 2023 | 251.85B | 67.53% |
| Dec 30, 2022 | 150.33B | 9.43% |
| Dec 31, 2021 | 137.38B | 74.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lupin | 1.01T |
| Abbott India | 580.42B |
| GlaxoSmithKline Pharmaceuticals | 443.81B |
| AstraZeneca Pharma India | 223.86B |
| Jubilant Pharmova | 148.25B |
| Granules India | 140.92B |
| Caplin Point Laboratories | 131.67B |
| Rubicon Research | 130.24B |